References
- Pesando J. M., Stucki M. A. AFTR A fifth human B-cell specific surface antigen. Human Immunology 1990; 27: 193–207, 1990.
- Van de Velde H., von Hoegen I., Luo W., Parnes J. R., Thielemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 1991; 351: 662–665
- Irvin J. D. Purification and properties of an antiviral protein from Phytolacca americana. Arch. Biochem. Biophys 1975; 169: 522–528
- Myers D. E., Irvin J. D., Smith R. S., Kuebelbeck V. M., Uckun F. M. Production of a pokeweed antiviral protein(PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B-lineage lymphoid differentiation antigen in highly purified form for human clinical trials. J. Immunol. Methods 1991; 136: 221–238
- Uckun F. M., Gajl-Peczalska K., Myers D. E., Jaszcz W., Haissig S., Ledbetter J. A. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma. Blood 1990; 76: 2449–2456
- Uckun F. M., Ramakrishnan S., Houston L. L. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. J. of Immunol 1985; 134: 2010–2016
- Uckun F. M., Chelstrom L. M., Finnegan D., Tuel-Ahlgren L., Manivel C., Irvin J. D., Myers D. E., Gunther R. Effective immunochemotherapy of CALLA+ Cu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43(anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide. Blood 1992; 79: 3116–3129
- Mantel N. Evaluation of survival data and two new rank order statistics rising in its consideration. Cancer Chemother. Rep 1966; 50: 163–170
- Matthews D. W., Farewell V. T. The log-rank of Mantel-Haenszel test for the comparison of survival curves. Using and Understanding Medical Statistics, D. W. Matthews, V. T. Farewell. Karger, Basel, Switzerland 1988; 79